We are live on ! Find out more
SLNO

Soleno Therapeutics
SLNO

Delisted

SLNO was delisted on the 15th of May, 2026.

Back to rankings

9 hedge funds and large institutions have $16.4M invested in Soleno Therapeutics in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $15.9M → $16.4M (+$473K)

18% less funds holding

Funds holding: 11 → 9 (-2)

42.51% less ownership

Funds ownership: 89.54% → 47.03% (-43%)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DZ Bank
DZ Bank
Germany
+$216K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$17.1K
3
SM
Sabby Management
Florida
+$4.96K
4
UBS Group
UBS Group
Switzerland
+$4.31K

Top Sellers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
-$39K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$29K
3
JP Morgan Chase
JP Morgan Chase
New York
-$2K

SLNO Hedge Fund Activity: Q1 2018 in Review

9 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Soleno Therapeutics (SLNO) for Q1 2018, worth a combined $16.4M — up 3% from $15.9M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SLNO and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was DZ Bank, opening a new position worth an estimated $216K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $39K sold.

  • 9 institutional investors held Soleno Therapeutics (SLNO) as of Q1 2018, down from 11 in Q4 2017.
  • Funds reported $16.4M of Soleno Therapeutics stock for Q1 2018, up 3% quarter-over-quarter.
  • 2 funds opened new Soleno Therapeutics positions in Q1 2018 and 4 closed out, a net change of -2 holders.
  • The largest Soleno Therapeutics buyer in Q1 2018 was DZ Bank, an estimated $216K added.
  • The largest Soleno Therapeutics seller in Q1 2018 was Two Sigma Securities, an estimated $39K sold.

Based on aggregated 13F filings for Q1 2018.